Prurigo nodularis and associated dermatological conditions in Finland from 1995 to 2022
This registry-based study analysed the epidemiology of prurigo nodularis in Finland from 1995 to 2022. Surprisingly, only one-fifth of Finnish patients with prurigo nodularis had a preceding dermatological diagnosis.
Authors
- Suvi‐Päivikki Sinikumpu (ORCID: https://orcid.org/0000-0001-6496-5475)
- Laura Huilaja (ORCID: https://orcid.org/0000-0002-7597-4323)
- Jari Jokelainen (ORCID: https://orcid.org/0000-0003-4629-0560)
Institutions
- Oulu University Hospital (FI)
- University of Oulu (FI)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1093/bjd/ljaf379
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Sanofi
- BioCryst
- LEO Pharma
- Sanofi Genzyme
- Cilag